Doctor of Podiatric Medicine Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

William Miller

Podiatrist, Foot Surgery Port Chester, NY Doctor of Podiatric Medicine

NPI 1003820655 CMS profile 363356

220 Grace Church St, Port Chester, NY 10573

Open in the dashboard

General payments

$1,909

59 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, William Miller of Port Chester, NY is reported in the CMS Open Payments database as having received $1,909 across 59 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 71st percentile of Podiatrist, Foot Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $129 4
2024 General $636 19
2023 General $482 17
2022 General $646 18
2020 General $15 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • William Miller
  • Podiatrist, Foot Surgery median
  • Middle half of Podiatrist, Foot Surgery
  • National median

In program year 2025, general payments to William Miller were reported at $129. Among 732 Podiatrist, Foot Surgery profiles paid that year, the median was $180 and the middle half received between $70 and $569.

Show as a table
Year William Miller Podiatrist, Foot Surgery median Middle half National median
2019 $0 $167 $67–$484 $163
2020 $15 $114 $40–$323 $114
2021 $0 $171 $57–$502 $132
2022 $646 $196 $66–$556 $149
2023 $482 $187 $78–$466 $160
2024 $636 $190 $78–$557 $164
2025 $129 $180 $70–$569 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Organogenesis Inc. $543 15 payments
  2. ConvaTec Inc. $265 2 payments
  3. Triad Life Sciences Inc. $169 2 payments
  4. Amgen Inc. $151 7 payments
  5. AbbVie, Inc. $144 6 payments
  6. Smith+Nephew, Inc. $130 4 payments
  7. Inari Medical, Inc. $77 2 payments
  8. Nevro Corp. $76 3 payments
  9. Horizon Therapeutics plc $70 2 payments
  10. Averitas Pharma Inc. $65 4 payments
  11. Other $218 12 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Food and Beverage $1,909 59 payments
Products named General payments · program years 2020–2025
  1. INNOVAMATRIX AC $434 4 payments
  2. Puraply $312 9 payments
  3. KRYSTEXXA Inflammation/Rare Disease $151 7 payments
  4. Bone Anchors with Arthroscopic Delivery System $113 3 payments
  5. PURAPLY WOUND MATRIX $105 1 payment
  6. DALVANCE $97 5 payments
  7. FLOWTRIEVER CATHETER, S $77 2 payments
  8. CT THROMBECTOMY SYSTEM KIT $77 2 payments
  9. KRYSTEXXA Krystexxa $70 2 payments
  10. Qutenza $65 4 payments
  11. Other $573 28 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 14 drugs

Part D claims

513

Median for Podiatry: 160

Drug cost

$7,839

Median for Podiatry: $2,368

Branded share of claims

8.8%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ciclopirox Generic 121 $4,063
Ammonium Lactate Generic 54 $652
Celecoxib Generic 36 $624
Ketoconazole Generic 42 $464
Gabapentin Generic 16 $343
Duloxetine Hcl Generic 40 $328
Diclofenac Sodium Generic 12 $278
Hydrocortisone Generic 42 $233
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 17 $195
Methylprednisolone Generic 19 $158

The 10 drugs with the highest cost, of 14 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 35 billing codes

Paid by Medicare

$277,237

Medicare's payments for the services billed

Medicare patients

386

Average age 76

Services billed

2,719

216 women, 170 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 52%
Diabetes 49%
Chronic kidney disease 31%
Ischemic heart disease 27%
Atrial fibrillation 21%
Heart failure 19%
COPD 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

5 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
KRYSTEXXA
  • Amgen Inc. $151
$151 — —
QULIPTA
  • AbbVie, Inc. $47
$47 — —
NUZYRA
  • Paratek Pharmaceuticals, Inc. $37
$37 — —
DALVANCE
  • AbbVie, Inc. $20
$20 — —
Qutenza
  • Averitas Pharma Inc. $14
$14 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

59 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record